{"entity":{"id":"nct07310784","kind":"trial","name":"A Phase II Trial of LM103 in Advanced Melanoma","aka":[],"tldr":"A phase 2 trial of Dacarbazine, Temozolomide, Paclitaxel / nab-paclitaxel in melanoma, run by Suzhou BlueHorse Therapeutics Co., Ltd., now recruiting.","summary":"A Phase II Trial of LM103 in Advanced Melanoma is a phase 2 interventional study registered as NCT07310784 by Suzhou BlueHorse Therapeutics Co., Ltd., with 92 participants planned, started 2025-12-16 and due to reach its primary completion in 2027-12-31. Interventions recorded: LM103 TILs Injection, Dacarbazine, temozolomide, paclitaxel, carboplatin/cisplatin. Conditions listed: Advanced Melanoma. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-16","links":[{"label":"ClinicalTrials.gov NCT07310784","url":"https://clinicaltrials.gov/study/NCT07310784"}],"tags":["ctgov-ingest"],"related":[],"cancers":["melanoma"],"sections":[],"technologies":[],"targets":[],"drugs":["dacarbazine","temozolomide","paclitaxel","carboplatin","cisplatin"],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"notes":[],"nct":"NCT07310784","phase":"2","setting":"A Multicenter, Randomized, Controlled, Open-label, Phase II Trial on Autologous Tumor Infiltrating Lymphocyte Injection (LM103 TILs) for the Treatment of Advanced Melanoma","sponsor":"Suzhou BlueHorse Therapeutics Co., Ltd.","enrolled":92,"outcomes":[]},"route":"/trials/nct07310784/","neighbours":{"cancer":[{"id":"melanoma","kind":"cancer","name":"Melanoma","route":"/cancers/melanoma/"}],"drug":[{"id":"carboplatin","kind":"drug","name":"Carboplatin","route":"/drugs/carboplatin/"},{"id":"cisplatin","kind":"drug","name":"Cisplatin","route":"/drugs/cisplatin/"},{"id":"dacarbazine","kind":"drug","name":"Dacarbazine","route":"/drugs/dacarbazine/"},{"id":"paclitaxel","kind":"drug","name":"Paclitaxel / nab-paclitaxel","route":"/drugs/paclitaxel/"},{"id":"temozolomide","kind":"drug","name":"Temozolomide","route":"/drugs/temozolomide/"}]}}